Format

Send to

Choose Destination
See comment in PubMed Commons below
Nutrients. 2017 May 25;9(6). pii: E535. doi: 10.3390/nu9060535.

Selected Risk Nutritional Factors for Chemotherapy-Induced Polyneuropathy.

Author information

1
Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. grimj@lfhk.cuni.cz.
2
Department of Research and Development, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. alena.ticha@fnhk.cz.
3
Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. alena.ticha@fnhk.cz.
4
Department of Research and Development, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. rhyspler@lfhk.cuni.cz.
5
Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. rhyspler@lfhk.cuni.cz.
6
Department of Neurology, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. martin.valis@fnhk.cz.
7
Department of Research and Development, University Hospital Hradec Kralove, 50005 Hradec Kralove, Czech. zdenek.zadak@fnhk.cz.

Abstract

The present study seeks to identify the nutritional risk factors involved in the development of neuropathies induced by chemotherapeutic treatments. Unlike the gastrointestinal or hematological adverse effects of chemotherapy there is no protective treatment strategy for polyneuropathy. The aim of this study was to find possible deficiencies in nutritional factors, which can be used for supplementation in the future for prevention of chemotherapy-induced neuropathy development. We analyzed 70 patients undergoing paclitaxel chemotherapy and evaluated the risk factors involved in chemotherapy-induced peripheral neuropathy (CIPN). Several risk factors were considered in the development of CIPN, including deficiency of vitamin B1, B6, and D and fatty acids. The occurrence of CIPN complication in 60% cases was observed. We found significant differences in vitamin D and saturated fatty acid concentration. Vitamin D levels in the group without CIPN were estimated to be 38.2 (24.95, 47.63) nmol/L, whereas in the group with CIPN it was determined to be 25.6 (19.7, 32.55) nmol/L, p = 0.008. The level of total saturated fatty acids in the group without CIPN was of 32.613 Area % (31.322; 36.262), whereas in the group with CIPN it was of 34.209 Area % (32.86; 39.386), p = 0.01. The obtained results suggest a diet lower in saturated fatty acid content during chemotherapy. The most significant finding was that supplementation of vitamin D before chemotherapy could be an efficient neuroprotective in CIPN prophylaxis, as significantly lower levels 25OH derivative of vitamin D were observed in the CIPN group throughout the study period.

KEYWORDS:

chemotherapy; fatty acids; polyneuropathy; vitamin B1; vitamin B6; vitamin D

PMID:
28587059
DOI:
10.3390/nu9060535
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Multidisciplinary Digital Publishing Institute (MDPI)
    Loading ...
    Support Center